Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China · Delayed Price · Currency is CNY 8.22
-0.38 (-4.42%)
Sep 10, 2026, 12:14 PM CST
SHE:300016 Revenue
Beijing Beilu Pharmaceutical had revenue of 352.96M CNY in the quarter ending June 30, 2026, with 17.06% growth. This brings the company's revenue in the last twelve months to 1.29B, up 18.34% year-over-year. In the year 2025, Beijing Beilu Pharmaceutical had annual revenue of 1.21B with 22.54% growth.
Revenue (ttm)
1.29B
Revenue Growth
+18.34%
P/S Ratio
3.86
Revenue / Employee
1.09M
Employees
1,188
Market Cap
5.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.21B | 221.72M | 22.54% |
| Dec 31, 2024 | 983.55M | 92.84M | 10.42% |
| Dec 31, 2023 | 890.72M | 124.84M | 16.30% |
| Jan 1, 2023 | 765.88M | -94.02M | -10.93% |
| Jan 1, 2022 | 859.91M | 32.57M | 3.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.